Semnur Pharmaceuticals, Inc. Repayments of Convertible Debt
Semnur Pharmaceuticals, Inc. (SMNR) had Repayments of Convertible Debt of $842.50 thousand as of 2023-12-29, per its 10-K filed 2024-04-01.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfConvertibleDebt · last filed 2024-04-01
- 2023-12-29: Repayments of Convertible Debt $842.50K.
- 2023-10-12: Repayments of Convertible Debt $642.50K.
| Period end | Repayments of Convertible Debt |
|---|---|
| 2023-12-29 | $842.50K 10-K · filed 2024-04-01 |
| 2023-10-12 | $642.50K 10-K · filed 2024-04-01 |